Oncology Institute (TOI) Invested Capital (2020 - 2025)
Oncology Institute (TOI) has disclosed Invested Capital for 6 consecutive years, with $63.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Invested Capital fell 40.27% year-over-year to $63.9 million, compared with a TTM value of $63.9 million through Sep 2025, down 40.27%, and an annual FY2024 reading of $96.7 million, down 32.76% over the prior year.
- Invested Capital was $63.9 million for Q3 2025 at Oncology Institute, down from $66.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $207.0 million in Q3 2022 and bottomed at $47.1 million in Q1 2021.
- Average Invested Capital over 5 years is $112.9 million, with a median of $107.0 million recorded in 2024.
- The sharpest move saw Invested Capital skyrocketed 386.22% in 2021, then crashed 44.58% in 2025.
- Year by year, Invested Capital stood at $104.3 million in 2021, then skyrocketed by 95.32% to $203.8 million in 2022, then fell by 29.41% to $143.9 million in 2023, then tumbled by 32.76% to $96.7 million in 2024, then plummeted by 33.91% to $63.9 million in 2025.
- Business Quant data shows Invested Capital for TOI at $63.9 million in Q3 2025, $66.0 million in Q2 2025, and $79.0 million in Q1 2025.